AP2009004849A0 - Pyrazole analogs - Google Patents

Pyrazole analogs

Info

Publication number
AP2009004849A0
AP2009004849A0 AP2009004849A AP2009004849A AP2009004849A0 AP 2009004849 A0 AP2009004849 A0 AP 2009004849A0 AP 2009004849 A AP2009004849 A AP 2009004849A AP 2009004849 A AP2009004849 A AP 2009004849A AP 2009004849 A0 AP2009004849 A0 AP 2009004849A0
Authority
AP
ARIPO
Prior art keywords
pyrazole analogs
pyrazole
analogs
Prior art date
Application number
AP2009004849A
Other languages
English (en)
Inventor
Matthew J Graneto
Todd Michael Maddux
Jamie Masferrer
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AP2009004849A0 publication Critical patent/AP2009004849A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
AP2009004849A 2006-11-27 2007-11-14 Pyrazole analogs AP2009004849A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86733706P 2006-11-27 2006-11-27
PCT/IB2007/003518 WO2008065493A1 (fr) 2006-11-27 2007-11-14 Analogues du pyrazole

Publications (1)

Publication Number Publication Date
AP2009004849A0 true AP2009004849A0 (en) 2009-06-30

Family

ID=39226772

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2009004849A AP2009004849A0 (en) 2006-11-27 2007-11-14 Pyrazole analogs

Country Status (32)

Country Link
US (1) US7772269B2 (fr)
EP (1) EP2097407A1 (fr)
JP (1) JP4469924B2 (fr)
KR (1) KR20090074264A (fr)
CN (1) CN101541790A (fr)
AP (1) AP2009004849A0 (fr)
AR (1) AR063924A1 (fr)
AU (1) AU2007327004A1 (fr)
BR (1) BRPI0718672A2 (fr)
CA (1) CA2667566C (fr)
CL (1) CL2007003403A1 (fr)
CO (1) CO6180447A2 (fr)
CR (1) CR10745A (fr)
CU (1) CU23801B7 (fr)
DO (1) DOP2009000121A (fr)
EA (1) EA016588B1 (fr)
EC (1) ECSP099328A (fr)
GE (1) GEP20125386B (fr)
GT (1) GT200700104A (fr)
HN (1) HN2007000505A (fr)
IL (1) IL198412A0 (fr)
MA (1) MA30924B1 (fr)
MX (1) MX2009005526A (fr)
NO (1) NO20092413L (fr)
NZ (1) NZ576376A (fr)
PE (1) PE20081299A1 (fr)
RS (1) RS20090211A (fr)
TN (1) TN2009000205A1 (fr)
TW (1) TW200831495A (fr)
UA (1) UA92833C2 (fr)
UY (1) UY30743A1 (fr)
WO (1) WO2008065493A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101918392A (zh) 2007-11-26 2010-12-15 辉瑞有限公司 作为5-lo抑制剂的吡唑衍生物
EP2151450A1 (fr) * 2008-07-29 2010-02-10 Sandoz AG Procédé de préparation d'oligopeptides cycliques microbiologiques
WO2011137363A1 (fr) * 2010-04-30 2011-11-03 Allergan, Inc. Nouveau traitement pour la dégénérescence maculaire liée à l'âge et la maladie ischémique oculaire associée à l'activation du complément par le ciblage de la 5-lipoxygénase
TWI527809B (zh) * 2011-01-24 2016-04-01 百靈佳殷格翰國際股份有限公司 作為ｃｒｔｈ２拮抗劑之吡唑化合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE913866A1 (en) * 1990-11-28 1992-06-03 Ici Plc Aryl derivatives
PL176522B1 (pl) 1993-06-14 1999-06-30 Pfizer Nowe pochodne imidazolu
US5883106A (en) * 1994-10-18 1999-03-16 Pfizer Inc. 5-lipoxygenase inhibitors
SK281577B6 (sk) * 1994-10-18 2001-05-10 Pfizer Inc. Heterocyklické zlúčeniny a farmaceutický prostriedok na ich báze
JP3400392B2 (ja) * 1994-10-18 2003-04-28 ファイザー製薬株式会社 ５−リポキシゲナーゼ阻害剤及び新規医薬組成物
DK0863905T3 (da) 1995-09-18 2001-01-02 Pfizer Imidazollipoxygenaseinhibitorer
US6194585B1 (en) * 1998-12-22 2001-02-27 Pfizer Inc. Process for preparing 5-lipoxygenase inhibitors
JP2001100686A (ja) * 1999-09-28 2001-04-13 Hitachi Kokusai Electric Inc 表示データ取込方法及び比較検査装置
JP2001100682A (ja) * 1999-09-28 2001-04-13 Sanyo Electric Co Ltd サインシステム

Also Published As

Publication number Publication date
TN2009000205A1 (fr) 2010-10-18
UY30743A1 (es) 2008-07-03
CU20090083A7 (es) 2011-09-21
US20080125474A1 (en) 2008-05-29
UA92833C2 (en) 2010-12-10
WO2008065493A1 (fr) 2008-06-05
CA2667566C (fr) 2012-01-03
KR20090074264A (ko) 2009-07-06
CN101541790A (zh) 2009-09-23
MX2009005526A (es) 2009-06-05
TW200831495A (en) 2008-08-01
US7772269B2 (en) 2010-08-10
MA30924B1 (fr) 2009-11-02
CA2667566A1 (fr) 2008-06-05
EA200970422A1 (ru) 2009-12-30
AR063924A1 (es) 2009-02-25
CR10745A (es) 2009-05-22
IL198412A0 (en) 2010-02-17
RS20090211A (sr) 2010-10-31
NZ576376A (en) 2011-02-25
JP4469924B2 (ja) 2010-06-02
EA016588B1 (ru) 2012-06-29
CL2007003403A1 (es) 2008-07-04
ECSP099328A (es) 2009-06-30
PE20081299A1 (es) 2008-09-17
HN2007000505A (es) 2010-06-09
NO20092413L (no) 2009-07-20
EP2097407A1 (fr) 2009-09-09
CU23801B7 (es) 2012-03-15
BRPI0718672A2 (pt) 2013-11-26
DOP2009000121A (es) 2009-06-15
GEP20125386B (en) 2012-01-25
JP2010511601A (ja) 2010-04-15
GT200700104A (es) 2011-04-13
AU2007327004A1 (en) 2008-06-05
CO6180447A2 (es) 2010-07-19

Similar Documents

Publication Publication Date Title
SI1999114T1 (sl) Pirazoli kot 11-beta-hsd-1
EP2166849A4 (fr) Composés pyrazole substitués
ZA201100471B (en) Pyrazole compounds 436
IL194438A0 (en) Diarylthiohydantoin compounds
IL192799A0 (en) Substituted 4-phenylpiperidines
EP1984379A4 (fr) Composes anti-arenaviridae
EP2084135A4 (fr) Pyrazoles
GB0611781D0 (en) 2-Oxo-2H-Chromene Compounds
EP2082022A4 (fr) Composés
IL198412A0 (en) Pyrazole analogs
GB0607175D0 (en) Compounds
EP2004174A4 (fr) Composés de naphtalènedione
GB0607398D0 (en) Compounds
ZA200903382B (en) Substituted 4-imidazoles
GB0614062D0 (en) Compounds
AP2009004767A0 (en) Cubstituted azolin-2-yl-amino compounds
EP1973905A4 (fr) Composes
ZA200808770B (en) Compounds
GB0623174D0 (en) Compounds
GB0614053D0 (en) Compounds
GB0600427D0 (en) Compounds
ZA200807959B (en) Pyrazoles as 11-Beta-HSD-1
GB0617866D0 (en) Jarjar (jaropener)
GB0605449D0 (en) 4c
HU0600193V0 (en) Latch-cover for water-network